Enter search term

Make the switch to ZEUS Borrelia MTTT™ - the complete solution for your Lyme-disease testing needs

Dec 17, 2020

Let us help you make the switch to ZEUS Borrelia MTTT™
Schedule your personalized 1:1 consultation today to learn how!

Making the switch to the ZEUS Borrelia Modified Two-Tiered Testing (MTTT™) algorithm gives you improved detection of early Lyme disease, allows you to replace outdated Lyme disease immunoblots, and increases overall lab workflow and efficiency.

But that's not all.

Partnering with ZEUS Scientific means partnering with over 40 years of experience in developing, manufacturing and delivering high-quality in vitro diagnostic (IVD) products. Particularly, ZEUS has been a pioneer in Lyme disease diagnostics. From the first FDA-cleared Lyme IVD device in 1987 to the only FDA-cleared Borrelia MTTT™ algorithm method of testing for Lyme disease in 2019, it is no wonder that ZEUS has been recently featured on Lifetime Network's Access Health program.

And now there's more.

While we continually provide support via our excellent sales and technical service teams, we are now offering individualized support with our resident Lyme disease experts. Schedule your one-on-one virtual consultation today and create a customized transition plan that works for you.

Schedule your 1:1

Make 2021 the year of improvement. Get started now by switching to the ZEUS Borrelia MTTT™ algorithm for a simpler, faster, and better way to detect early Lyme disease.


ZEUS Borrelia MTTT™ uses two rounds of ELISA tests, enabling simple and flexible first-tier and second-tier testing in-house with an automation-friendly approach. This translates to simplified Lyme disease testing processes and improved detection of early Lyme disease. Earlier diagnosis equals earlier treatment.


The ZEUS Borrelia MTTT™ reduces turnaround time, allowing patients to access much-needed treatment earlier. Without early treatment, Lyme disease can have a devastating impact on patients.


Our updated algorithm detected up to 30% more clinically confirmed positive patients in acute early Lyme disease, the critical time to correctly identify and treat! Reducing the number of missed clinically positive patient samples especially in early Lyme disease stages 1 and 2 can make a real difference in a person’s life.


Trust the experts in Lyme disease testing.
Test with Confidence. Test with ZEUS.

Simplify your testing. Contact ZEUS today!

Visit zeuslyme.com to learn more.



The ZEUS Scientific Team

Back Share